Cargando…

Pharmacological targeting EZH2 to modulate chronic graft-versus-host disease

Detalles Bibliográficos
Autor principal:	Wang, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742112/ https://www.ncbi.nlm.nih.gov/pubmed/36518590 http://dx.doi.org/10.1097/BS9.0000000000000125

Ejemplares similares

Graft-versus-host disease may cause pulmonary restriction, but not all restriction is graft-versus-host disease
por: Sheshadri, Ajay, et al.
Publicado: (2022)

Microbiome: an emerging new frontier in graft‑versus‑host disease
por: Kumari, Reena, et al.
Publicado: (2020)

A question of persistence: Langerhans cells and graft-versus-host disease
por: Collin, Matthew, et al.
Publicado: (2014)

Commentary: Ocular graft versus host disease: Need for multidisciplinary care
por: Shanbhag, Swapna S, et al.
Publicado: (2021)

High-choline diets ameliorate acute graft-versus-host disease
por: Hu, Bo, et al.
Publicado: (2020)

Targeting Histone Deacetylases to Modulate Graft-Versus-Host Disease and Graft-Versus-Leukemia
por: Kim, Sena, et al.
Publicado: (2020)

Graft-versus-host disease: establishing IL-33 as an important costimulatory molecule
por: Ferrara, James, et al.
Publicado: (2022)

American Society of Hematology 2020 Podcast Collection: Graft-Versus-Host Disease
por: Mariotti, Jacopo
Publicado: (2021)

Having it both ways: how STAT3 deficiency blocks graft-versus-host disease while preserving graft-versus-leukemia activity
por: Brandstadter, Joshua D., et al.
Publicado: (2023)

Regulatory T Cells and Ocular Graft Versus Host Disease: A Novel Treatment Approach
por: Pishnamaz, Mohammad Reza, et al.
Publicado: (2018)

Commentary: Ocular surface involvement heralds graft-versus-host disease: Time to act
por: Narang, Purvasha, et al.
Publicado: (2020)

Graft-versus-Host Disease Modulation by Innate T Cells
por: Fang, Ying, et al.
Publicado: (2023)

The Role of B Cell Targeting in Chronic Graft-Versus-Host Disease
por: Rhoades, Ruben, et al.
Publicado: (2017)

Fatty acid metabolism and drug resistance to EZH2 inhibition
por: Wang, Yemin
Publicado: (2022)

Oral Chronic Graft-Versus-Host Disease
por: Dean, David, et al.
Publicado: (2022)

Progress in chronic graft-versus-host disease
por: Martin, Paul J
Publicado: (2011)

Advance in Targeted Immunotherapy for Graft-Versus-Host Disease
por: Zhang, Lingling, et al.
Publicado: (2018)

Role of Vitamin A in Modulating Graft-versus-Host Disease
por: Zheng, Jianwei, et al.
Publicado: (2018)

Targeting CD83 for the treatment of graft-versus-host disease
por: WANG, XIONGFEI, et al.
Publicado: (2013)

Modulation and Apoptosis of Neutrophil Granulocytes by Extracorporeal Photopheresis in the Treatment of Chronic Graft-Versus-Host Disease
por: Franklin, Cindy, et al.
Publicado: (2015)

Follicular Graft-versus-host Disease: A Rare Manifestation in a Patient with the Overlap Subtype of Chronic Graft-versus-host Disease
por: Ho, Yi-Hsin, et al.
Publicado: (2019)

The pathophysiology of chronic graft-versus-host disease: the unveiling of an enigma
por: Min, Chang-Ki
Publicado: (2011)

Treatment of Tularemia in Patient with Chronic Graft-versus-Host Disease
por: Weile, Jan, et al.
Publicado: (2013)

Chronic Cutaneous Graft versus Host Disease Mimicking Warts
por: Lee, Bo In, et al.
Publicado: (2015)

Therapeutic effects of hydrogen on chronic graft‐versus‐host disease
por: Qian, Liren, et al.
Publicado: (2017)

Potential Novel Biomarkers in Chronic Graft-Versus-Host Disease
por: Crossland, Rachel E., et al.
Publicado: (2020)

Challenges in Conducting Studies in Chronic Graft-versus-Host Disease
por: Pusic, Iskra, et al.
Publicado: (2019)

Extracorporeal Photopheresis in Children with Chronic Graft-Versus-Host Disease
por: Kozlov, Andrey, et al.
Publicado: (2021)

Isomorphic Sclerotic-Type Cutaneous Chronic Graft-Versus-Host Disease: Report and Review of Chronic Graft-Versus-Host Disease in a Cutaneous Immunocompromised District
por: Cohen, Philip R.
Publicado: (2013)

S240: TARGETING PRMT1 ALLEVIATES CHRONIC GRAFT-VERSUS-HOST DISEASE BY REDUCING T AND B PATHOGENICITY
por: Zhao, Xiaoyan, et al.
Publicado: (2023)

SGK1, a Critical Regulator of Immune Modulation and Fibrosis and a Potential Therapeutic Target in Chronic Graft-Versus-Host Disease
por: Lu, Run-qing, et al.
Publicado: (2022)

Role of STAT3 in regulatory T lymphocyte plasticity during acute graft-vs.-host-disease
por: Fujino, Masayuki, et al.
Publicado: (2013)

T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor
por: Jiang, Hua, et al.
Publicado: (2021)

Multiple spider angiomas in a patient with chronic hepatic graft-versus-host disease
por: Gu, Ying, et al.
Publicado: (2020)

Gene expression profile of chronic oral graft-versus-host disease
por: Pinto, Giselle Rocha, et al.
Publicado: (2022)

MicroRNA serum profiles and chronic graft-versus-host disease
por: Reikvam, Håkon, et al.
Publicado: (2022)

A Rare Presentation of Acute on Chronic Graft Versus Host Disease
por: Khurana, Surbhi, et al.
Publicado: (2022)

Treatment of chronic graft-versus-host disease: Past, present and future
por: Martin, Paul J., et al.
Publicado: (2011)

Early and late oral features of chronic graft-versus-host disease
por: Gomes, Alessandra Oliveira Ferrari, et al.
Publicado: (2014)

Calcinosis Cutis Related to Sclerodermatous Chronic Graft Versus Host Disease
por: Lipshutz, Gabriel H., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_rl9pd4rfmmsbm8t43hv4j8irdv